Date published: 2026-5-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

CD209e Activators

CD209e is a gene that encodes a protein associated with the immune response in Mus musculus, the common house mouse. This protein, often referred to as SIGNR4, is an integral component of the immune system's ability to recognize and bind specific carbohydrate structures found on the surfaces of pathogens. Such recognition is crucial as it can trigger a cascade of immune responses aimed at defending the organism from infectious agents. The CD209e antigen is thought to be involved in processes such as endocytosis, where cells engulf foreign particles, and it is posited to operate primarily on the external side of the plasma membrane. By virtue of its location and function, CD209e plays a role in the frontline defense of the immune system. The protein's presence and activity are integral to the body's efforts to maintain vigilance against infections. Research into CD209e's behavior and expression patterns provides valuable insights into the complex network of signals that govern the immune system's responses to pathogens.

In the context of immunological research, certain chemicals have garnered attention for their potential to induce the expression of proteins like CD209e. These chemicals serve as tools to understand the protein's role and regulation within immune pathways. For instance, compounds such as lipopolysaccharides (LPS) and synthetic double-stranded RNA mimics like Poly I:C are known to activate toll-like receptors, which can stimulate the expression of various immune response genes. Vitamin D3 is another such compound that, through its role in the differentiation of immune cells, could potentially increase the expression of CD209e. Similarly, compounds like imiquimod and resiquimod, which target specific toll-like receptors involved in antiviral responses, could induce the upregulation of CD209e. The exploration of these chemical activators is driven by a scientific interest in mapping the gene expression landscape of immune cells and understanding the molecular mechanisms underlying immune surveillance. By studying these interactions, researchers can gain a deeper understanding of the innate immune system and the regulatory networks that control the expression of proteins critical for pathogen detection and response.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lipopolysaccharide, E. coli O55:B5

93572-42-0sc-221855
sc-221855A
sc-221855B
sc-221855C
10 mg
25 mg
100 mg
500 mg
$98.00
$171.00
$425.00
$1560.00
12
(2)

LPS might upregulate CD209e expression by initiating a cascade through TLR4 signaling, leading to transcriptional activation of immune-related genes, including those encoding for pathogen recognition receptors like CD209e.

Imiquimod

99011-02-6sc-200385
sc-200385A
100 mg
500 mg
$67.00
$284.00
6
(1)

Imiquimod may induce the expression of CD209e through the activation of TLR7, resulting in an enhanced antiviral state that necessitates the upregulation of virus-detecting receptors, such as CD209e.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

Cholecalciferol could stimulate the expression of CD209e by promoting the differentiation of dendritic cells, which would increase the need for pathogen recognition receptors on their surfaces to initiate an immune response.

R-848

144875-48-9sc-203231
sc-203231A
sc-203231B
sc-203231C
5 mg
25 mg
100 mg
500 mg
$102.00
$306.00
$510.00
$1559.00
12
(1)

R-848 may induce CD209e expression by activating TLR7 and TLR8, triggering a series of intracellular events that culminate in the upregulation of genes associated with pathogen detection and immune activation.

Zymosan

9010-72-4sc-296863
sc-296863A
100 mg
1 g
$99.00
$599.00
1
(0)

Zymosan could induce CD209e expression through dual activation of TLR2 and dectin-1 pathways, which are part of the immune response to fungal pathogens and may trigger the need for increased expression of receptors like CD209e on immune cells.

Pam3Cys-Ser-(Lys)4, Hydrochloride

112208-00-1sc-507471
2 mg
$550.00
(0)

Pam3CSK4 may upregulate CD209e expression by acting as a synthetic bacterial lipopeptide that engages TLR1/2, leading to an immune response that includes the induction of pathogen recognition receptors.